Moderate to Severe Acute Ischaemic Stroke: Clinical Trials

1 trial for Moderate to Severe Acute Ischaemic Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow Moderate to Severe Acute Ischaemic Stroke: new trials by email Literature Review of Moderate to Severe Acute Ischaemic Stroke trials Research Report on Moderate to Severe Acute Ischaemic Stroke

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke
Neflamapimod, Placebo - Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke
Phase 2Active not recruitingEIP Pharma Inc902025-06-202026-07-08

Narrower conditions

Ischemic Stroke (1)

Broader conditions

Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Nervous System Diseases (1)  ·  Stroke (1)  ·  Vascular Diseases (1)

Interventions

VX-745 (1)

Sponsors

EIP Pharma Inc (1)

Countries

Australia (1)